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This editorial refers to ‘Automated quantification of coron-
ary plaque with computed tomography: comparison with
intravascular ultrasound using a dedicated registration al-
gorithm for fusion-based quantification’†, by M.J. Boogers
et al., on page 1007
The modern paradigm of unstable plaques has led to the abandon-
ment of the central role of luminal narrowing as a risk factor of
plaque rupture and embraced an integrated concept of plaque vul-
nerability including a variety of microanatomical features such as
plaque size, lipid content of the core, fibrous cap thickness, and
positive plaque remodelling.1,2 A large number of studies have
documented a high diagnostic accuracy of coronary computed
tomography angiography (CCTA) to detect coronary stenoses
(a finding with strong clinical implications). However, unlike inva-
sive angiography, CCTA can provide non-invasive visualization of
the vessel wall, including information regarding plaque size,
extent, composition, and arterial remodelling. Several studies
have demonstrated that beyond coronary stenoses, the presence
of non-obstructive plaques is associated with an increased risk
for cardiovascular events.3 Confirmation of these findings
emerged from the recent multinational, multiethnic CONFIRM
registry, including .23 000 patients where the presence of
non-obstructive coronary disease was associated with a 50–70%
increase in total mortality.4
CCTA has an excellent accuracy to detect coronary plaques
compared with the gold standard intravascular ultrasound
(IVUS), with an area under the curve for the receiver operating
characteristics analysis of 0.94, a sensitivity of 90%, and a specificity
of 92%.5 The sensitivity is highest for the right coronary artery
(RCA), and lowest for the circumflex artery (LCX). Several
studies have assessed the value of CCTA for the quantification
of the extent of coronary atheroma. Leber and colleagues
showed that plaque volumes assessed with 64-slice CCTA corre-
lated well with IVUS (r ¼ 0.83).6 Unfortunately, depiction of
further microanatomical details such as the presence of a thin
fibrous cap is beyond the spatial resolution of current CCTA
devices, although some thin-cap fibroatheromas may produce a
ring-like enhancement on CCTA.7
Several plaque characteristics on CCTA are associated with
acute ischaemic events. A few small retrospective studies have
consistently shown that culprit lesions of acute coronary
syndromes (ACS) had larger vessel areas, more positive remodel-
ling, and a higher proportion of non-calcified and mixed plaque
components.5 Hoffmann et al. demonstrated a significantly larger
plaque area (17.5 vs. 13.5 mm2) and a higher remodelling index
(1.4 vs. 1.2) in culprit lesions of ACS patients, compared with
patients with stable angina.8 One retrospective study in 71 patients
showed that culprit lesions in patients with ACS had more positive
remodelling (87% vs. 12%), more low-density [,30 Hounsfield
units (HU)] plaque components (79% vs. 9%), and a higher preva-
lence of ‘spotty’ calcifications (63% vs. 21%).9 A prospective valid-
ation study confirmed the former two features as significant
predictors of ACS in more than .1000 patients.10 Thus, the
CCTA-based evaluation of plaque size and composition appears
an attractive new avenue to determine individual risks of cardiovas-
cular events.
Boogers and co-workers have validated the use of an automated
quantitative software (QCT) developed at their institution for the
assessment of coronary plaques and stenoses with CCTA.11 The
standard of reference is IVUS in 51 patients, and co-registration
of CT and IVUS images is performed using a dedicated fusion soft-
ware. This ‘hybrid’ approach allows superposition of IVUS runs on
multiplanar straight CCTA reconstructions using anatomical land-
marks such as side branches or calcified spots to ascertain appro-
priate co-registration along the long axis and the circumference of
the vessel. By this means, it facilitates obtaining and comparing
measurements from corresponding lesions interrogated by QCT
and IVUS. The authors find a reasonably good correlation
between both techniques for minimal luminal area (MLA), lumen
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area stenosis, plaque burden, and vascular remodelling index, with
correlation coefficients ranging from 0.56 (for remodelling index)
to 0.79 (for lumen area stenosis). They report a significant under-
estimation of MLA with a significant overestimation of luminal area
stenosis by QCT. Similarly, mean plaque burden was significantly
overestimated by QCT. Importantly, the authors also highlight
that low image quality and coronary calcifications may interfere
with accurate QCT.
With this report, Boogers and co-workers add important data
to the existing albeit small body of published literature comparing
CCTA measurements of coronary plaque extent and vascular re-
modelling with an invasive gold standard (IVUS), and their results
deserve closer attention.5 Studies of this kind can only be success-
fully performed in an environment where experienced operators
collaborate in the fields of non-invasive and invasive imaging, and
the investigators of this study should be commended for their
high level of skills. As outlined above, the reported indices repre-
sent important measurements of plaque size and extent which
have proven to correlate with cardiovascular events on follow-up
and therefore in the future could be used to assess non-invasively
individual ‘plaque risks’ and tailor personalized treatment strat-
egies. Additionally, repeat imaging studies would offer the potential
to assess the effect of treatment strategies on individual measures
of plaque risk. Yet, significant barriers stand between these early
promising reports and their wide clinical application. Previous
studies have shown moderate correlation coefficients for luminal
area stenosis12 and plaque volumes6 between CCTA and IVUS.
Interobserver variability for determining plaque volumes with
CCTA ranges from 17% to 37% depending on image quality,
vessel size, and presence or absence of calcifications.6,13,14 Given
the lower spatial resolution of CCTA compared with intravascular
imaging modalities, this raises questions about the reproducibility
of CCTA measurements of plaque size and extent. Naturally,
some of these inaccuracies could be partly explained by the fact
that the exact site of measurement along a diseased coronary
artery did not correspond between different observers due to
the lack of a standardized co-registration algorithm. With the use
of dedicated automated quantification software with fusion of cor-
responding CCTA and IVUS segments, Boogers and colleagues
eliminate such confounding factors. Nonetheless, the reported
variability (as assessed by Bland–Altman limits of agreement)
between QCT and IVUS is 53% for luminal area stenosis and
43% for mean plaque burden, demonstrating that indeed when
compared with IVUS, QCT offers limited accuracy and robustness
to determine plaque size and extent. Whether this is enough for
adopting CCTA quantitative plaque measurements as a surrogate
marker for efficacy of therapeutic treatment strategies remains
questionable.
Interestingly, Boogers and co-workers reported a systematic
underestimation of MLA and a systematic overestimation of
luminal area stenosis with QCT compared with IVUS. Other
reports indicated good agreement between CTA and IVUS for
plaque area and volume measurements, albeit with a certain level
of statistical heterogeneity.5 On average, CCTA slightly overesti-
mates plaque luminal area and plaque volume and underestimates
luminal area stenosis (i.e. in contrast to the present results by
Boogers); however, conflicting results can be found among differ-
ent study groups.5,12 This is probably related to the presence or
absence of coronary calcifications which, owing to the limited
spatial resolution of CCTA, may result in partial volume effects.
Accordingly, calcified lesions appear larger due to significant
partial volume effects (blooming artefacts) from the very dense
Figure 1 Conceptual graphics illustrating how invasive and non-invasive imaging modalities could combine to provide an integrated assess-
ment of microanatomical and biological features of an unstable coronary plaque. CCTA, CT coronary angiography; IVMR, intravascular magnetic
resonance; IVUS, intravascular ultrasound; NIRF, near-infrared fluoroscopy; NIRS, near-infrared spectroscopy; OCT, optical coherence
tomography.
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calcific deposits, and therefore plaque volume is overestimated
and MLA underestimated. Conversely, in non-calcified lesions
there is a partial volume effect from the contrast-filled coronary
lumen which results in overestimation of luminal area and under-
estimation of plaque volume. Boogers’ study population had high
calcium scores (mean 595) which explains the lower MLA and
higher luminal area stenosis. Moreover, image quality strongly
affects interobserver variability, which is lowest for plaque
volumes in the proximal segments of the left anterior descending
artery (LAD) (17%) and highest for the RCA (32%).14 Plaque
volume and variability have a significant inverse relationship, and
reproducibility is better in non-calcified than in calcified
lesions.13 However, the exact relationship between estimates of
local calcifications and measurements of plaque size and extent
on CCTA remain uncertain and should be subject to further sys-
tematic investigations.
These open questions should encourage further research into
the value CCTA for the non-invasive evaluation of coronary
lesions. Technical developments in the field of CCTA march at
an incredible pace. The spatial and temporal resolution of CCTA
is ever improving in fourth-generation devices. The use of dual
energy may allow spectral CT, which could allow the identification
of types of tissue based on their characteristic energy-dependent
photon attenuation, and may thereby allow identification and
selective extraction of different qualitative plaque components
such as calcifications, or fibrous and lipid-rich components. The
‘hybrid’ approach proposed by Boogers and colleagues provides
an excellent platform to validate these new advances against inva-
sive gold standards such as virtual histology–IVUS or optical co-
herence tomography. An unresolved issue is whether CCTA can
distinguish between predominantly lipid-rich and fibrous plaques
based on the CT density measured in HU. Several comparisons
between CCTA and IVUS have delivered conflicting results, par-
ticularly with a large overlap in HU between predominantly
lipid-rich and fibrous plaques. Presumably the lack of a standar-
dized co-registration algorithm between CCTA and IVUS would
explain some of this overlap. Additionally, a hybrid approach
would allow combining other intravascular techniques such as
near-infrared spectroscopy, intravascular magnetic resonance,
thermography, or intravascular positron detection, with CCTA
closing a bridge between invasive and non-invasive coronary
imaging (Figure 1). By breaking the boundaries of traditional
imaging and combining information from different domains, we
could potentially improve our understanding of the vulnerability
of individual coronary plaques and in the future offer our patients
a tailored and personalized approach to reducing individual risk.
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